sabcs 2020: monarche, penelope-b, tailorx & ascent
Published 3 years ago • 266 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
1:28
highlights from sabcs 2020
-
2:37
sabcs 2020: endocrine combination therapy & adjuvant chemotherapy in node-positive patients
-
0:29
upcoming trial updates at sabcs 2020
-
0:35
what to look forward to at sabcs 2020?
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
1:48
exciting updates from sabcs 2020
-
2:10
b s achema management statements management
-
3:13
mona's story: battling advanced breast cancer
-
30:20
advanced biologics in spine surgery - steven schopler, m.d.
-
1:28
upcoming advances in precision medicine at sabcs 2020
-
0:30
exciting trial updates from the upcoming sabcs 2020 meeting
-
1:08
4-year monarche results: increasing benefits with abemaciclib et for er /her2- high-risk early bc
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
0:31
upcoming data from sabcs 2020
-
1:06
sabcs 2022 highlights
-
1:59
monarche: patient-reported outcomes
-
0:55
key highlights from sabcs 2022
-
16:12
sabcs 2022: overall survival analysis of the randomized stic ctc trial
-
10:15
copanlisib and fulvestrant with abemaciclib in her-, er breast cancer